 Responding to increasing development costs of new drugs and a perception that the pharmaceutical industry needed more international fusions, Astra started to look for partners.On December 9, 1998 plans for a fusion with Zeneca was announced, which would create the world's third largest pharmaceutical company.Despite some initial criticism of the plans, owners representing 96.4% of the stock voted for the fusion, which was effected in 1999.